1. How Important is Onset of Action in Ulcerative Colitis Therapy?

   • Steven Masson
   • David Nylander
   • John C. Mansfield

   Current Opinion 17 September 2012 Pages: 2069 - 2083

   

2. Treatment of Epidermal Necrolysis with High-Dose Intravenous Immunoglobulins (IVIg)

   • Ousmane Faye
   • Jean-Claude Roujeau

   Leading Article 17 September 2012 Pages: 2085 - 2090

   

3. Modern Malaria Chemoprophylaxis

   • G. Dennis Shanks
   • Michael D. Edstein

   Review Article 17 September 2012 Pages: 2091 - 2110

   

4. Pharmacological Treatment of Ankylosing Spondylitis

   • Pauline Boulos
   • Maxime Dougados
   • Elke Hunsche

   Review Article 17 September 2012 Pages: 2111 - 2127

   

5. Lansoprazole

   • Katherine F. Croom
   • Lesley J. Scott

   Adis Drug Profile 17 September 2012 Pages: 2129 - 2135

   

6. Lansoprazole in the Treatment of Gastrooesophageal Reflux Disease in Children and Adolescents

   • Vasundhara Tolia

   Adis Drug Profile 17 September 2012 Pages: 2136 - 2136

7. Lansoprazole in the Treatment of Gastro-oesophageal Reflux Disease in Children and Adolescents

   • Yvan Vandenplas
   • Silvia Salvatore

   Adis Drug Profile 17 September 2012 Pages: 2136 - 2137

8. Palifermin

   • M. Asif A. Siddiqui
   • Keri Wellington

   Adis Drug Profile 17 September 2012 Pages: 2139 - 2146

   

9. Palifermin in Myelotoxic Therapy-Induced Oral Mucositis

   • Mohamad Mohty
   • Didier Blaise

   Adis Drug Profile 17 September 2012 Pages: 2147 - 2147

10. Palifermin in Myelotoxic Therapy-Induced Oral Mucositis

    • Nicole M. A. Blijlevens
    • Shaun McCann

    Adis Drug Profile 17 September 2012 Pages: 2147 - 2147

11. Palifermin in Myelotoxic Therapy-Induced Oral Mucositis

    • Douglas E. Peterson

    Adis Drug Profile 17 September 2012 Pages: 2147 - 2147

12. Palifermin in Myelotoxic Therapy-Induced Oral Mucositis

    • Stephen T. Sonis

    Adis Drug Profile 17 September 2012 Pages: 2147 - 2149

13. Ertapenem

    • Gillian M. Keating
    • Caroline M. Perry

    Adis Drug Evaluation 17 September 2012 Pages: 2151 - 2178

    

14. Infliximab

    • M. Asif A. Siddiqui
    • Lesley J. Scott

    Adis Drug Evaluation 17 September 2012 Pages: 2179 - 2208

    

15. Nelfinavir

    • Caroline M. Perry
    • James E. Frampton
    • Risto S. Cvetković

    Adis Drug Evaluation 17 September 2012 Pages: 2209 - 2244